Interleukin-2-inducible T cell kinase inhibitor 2 (Corvus Pharmaceuticals)

N/A

Report date: 2024/05/16 17:28:49
NME

Base Information

Drug NameInterleukin-2-inducible T cell kinase inhibitor 2 (Corvus Pharmaceuticals)
Drug Alias NameITKi#2
ClassificationOther
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorvus Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCorvus Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A